Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, August 18, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Biotech
Biotech
Biotech
Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis
Life Sciences Times
-
August 18, 2026
Biotech
Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline
Life Sciences Times
-
August 18, 2026
Biotech
Enveda Reports Positive Phase 1 Results for ENV-308
Life Sciences Times
-
August 18, 2026
Biotech
Aizen Therapeutics Signs Oral Biologics Collaboration Worth Up to $100 Million Per Target
Life Sciences Times
-
August 17, 2026
Biotech
Hypertrophic Cardiomyopathy Market Reached $3.2 Billion in 2025, DelveInsight Says
Life Sciences Times
-
August 17, 2026
Biotech
Obsidian Enrolls First Patient in Registration-Enabling Amsoki-cel Melanoma Cohort
Life Sciences Times
-
August 5, 2026
0
Biotech
Enveric Reports Preclinical Data Supporting Non-Hallucinogenic Profile of EB-003
Life Sciences Times
-
August 5, 2026
0
Biotech
SOPHiA GENETICS Raises 2026 Revenue Outlook After Second-Quarter Sales Rise 27 Percent
Life Sciences Times
-
August 4, 2026
0
Biotech
Satellite Bio Receives FDA Clearance to Begin Trial of Liver Cell Therapy for Urea Cycle Disorders
Life Sciences Times
-
August 4, 2026
0
Biotech
Sunflower Therapeutics Receives $2 Million NIH Grant for VLP Manufacturing Technology
Life Sciences Times
-
August 4, 2026
0
Biotech
Vertex Raises 2026 Revenue Outlook After Second-Quarter Sales Rise 12 Percent
Life Sciences Times
-
August 4, 2026
0
Biotech
Revvity Raises 2026 Outlook After Second-Quarter Earnings Increase
Life Sciences Times
-
August 4, 2026
0
Biotech
BostonGene Wins Three Honors in 2026 Artificial Intelligence Excellence Awards
Life Sciences Times
-
August 4, 2026
0
Biotech
Stoke Therapeutics Completes Enrollment in Phase 3 Dravet Syndrome Study
Life Sciences Times
-
August 4, 2026
0
Biotech
CREATE Medicines Cleared to Begin Phase 1/2 Trial of In Vivo CAR-T Therapy for Autoimmune Diseases
Life Sciences Times
-
August 3, 2026
0
Biotech
Decoy Therapeutics Expands Patent Portfolio for Antiviral Platform
Life Sciences Times
-
August 3, 2026
0
Biotech
Biocon Launches Eylea Biosimilar Yesafili in the United States
Life Sciences Times
-
August 3, 2026
0
1
2
3
4
...
107
Page 3 of 107
Most Read
Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis
August 18, 2026
Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer
August 18, 2026
Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline
August 18, 2026
Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs
August 18, 2026